Looking at the underlying holdings of the ETFs in our coverage universe at &l;a href=&q;https://www.etfchannel.com/&q; target=&q;_blank&q;&g;ETF Channel&l;/a&g;, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.&a;nbsp; For the iShares Core Dividend Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $39.50 per unit.
With DGRO trading at a recent price near $35.25 per unit, that means that analysts see 12.04% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of DGRO&s;s underlying holdings with notable upside to their analyst target prices are Core Mark Holding, Advanced Drainage Systems and Simpson Manufacturing. Although CORE has traded at a recent price of $27.88/share, the average analyst target is 15.97% higher at $32.33/share. Similarly, WMS has 14.71% upside from the recent share price of $25.50 if the average analyst target price of $29.25/share is reached, and analysts on average are expecting SSD to reach a target price of $69.00/share, which is 12.41% above the recent price of $61.38.
Best Dividend Stocks To Invest In 2019: Salesforce.com Inc(CRM)
Advisors' Opinion:- [By Daniel Sparks]
With the company seemingly firing on all cylinders, investors will scrutinize Salesforce's second-quarter results closely. In addition, investors will likely pay particularly close attention to any forward-looking commentary provided in the second-quarter update. Specifically, thanks to Salesforce's strong performance recently and its higher stock price, investors should look for the customer relationship management (CRM) platform provider to raise its outlook for full-year revenue.
- [By Jon C. Ogg]
Salesforce.com Inc. (NYSE: CRM) was reiterated as Outperform and the price target was raised to $140 from $125 at JMP Securities.
Viavi Solutions Inc. (NASDAQ: VIAV) was raised to Buy from Hold with a $15 price target (versus a $9.92 close) at Argus. The firm sees accelerating growth prospects around the coming 5G expansion.
- [By Daniel Sparks]
Square's valuation was undoubtedly becoming a little stretched at $100 per share. The company's price-to-sales ratio was closing in on 15 -- well ahead of competitors like Salesforce.com (NYSE:CRM) and Intuit (NASDAQ:INTU). But now Square's price-to-sales ratio of 10 puts it only at a slight premium to these same peers who both have price-to-sales ratios of about 9.
- [By Joe Tenebruso]
It's been an incredible decade for Salesforce.com (NYSE:CRM). Shares of the cloud-software titan are up a staggering 1,600% during this time, fueled by the torrid growth of the customer relationship management software market, intelligent acquisitions, and the rapid acceleration of cloud-based computing.
- [By Jon C. Ogg]
Salesforce.com Inc. (NYSE: CRM) was down 3.6% at $158.50 on Monday’s close ahead of its results. Robert W. Baird reiterated it as Outperform and raised the price target to $175 from $165. Wedbush reiterated its Outperform rating and raised its target to $192 from $174, and Macquarie reiterated its Outperform rating as well, raising its target to $188 from $174.
Best Dividend Stocks To Invest In 2019: Rowan Companies Inc.(RDC)
Advisors' Opinion:- [By Matthew DiLallo]
While September was a good month for Ensco, the company made an even bigger splash in October by agreeing to buy fellow offshore driller Rowan (NYSE:RDC) in an all-stock deal. Ensco believes that the combination with Rowan will generate $150 million in annual cost savings while boosting its cash flow per share starting in 2020. It's the company's second major deal since the oil market downturn began; it bought Atwood Oceanics last year for $6.9 billion.
- [By Travis Hoium, Jason Hall, and Matthew DiLallo]
And while offshore still has a ways to go, I think investors should do well to buy Ensco at current prices. At recent prices, its shares trade for about 24% of tangible book value. Furthermore, it's also a 23% discount to the book value of Rowan Companies (NYSE:RDC), which will merge with Ensco sometime in the first half of the year. It's a substantial discount to more typical book value multiples these companies have carried during healthy offshore drilling environments:
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss. Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings. Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance. Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results. Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday. BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years. Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint. Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results. Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates. Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings. Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share. Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m - [By Logan Wallace]
Ordocoin (CURRENCY:RDC) traded up 2.1% against the U.S. dollar during the 24 hour period ending at 18:00 PM Eastern on September 22nd. One Ordocoin token can currently be purchased for about $0.0001 or 0.00000001 BTC on exchanges including Crex24, BiteBTC and Stocks.Exchange. In the last seven days, Ordocoin has traded 2.8% higher against the U.S. dollar. Ordocoin has a market cap of $0.00 and approximately $53,260.00 worth of Ordocoin was traded on exchanges in the last 24 hours.
Best Dividend Stocks To Invest In 2019: WhiteHorse Finance, Inc.(WHF)
Advisors' Opinion:- [By Logan Wallace]
Get a free copy of the Zacks research report on WhiteHorse Finance (WHF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
WhiteHorse Finance Inc (NASDAQ:WHF) announced a quarterly dividend on Monday, September 10th, Wall Street Journal reports. Investors of record on Tuesday, September 18th will be given a dividend of 0.355 per share by the investment management company on Wednesday, October 3rd. This represents a $1.42 dividend on an annualized basis and a yield of 9.82%. The ex-dividend date is Monday, September 17th.
No comments:
Post a Comment